[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
November NaN, 2000

Tissue Engineering Approaches Utility

Author Affiliations

Not Available

Not Available

JAMA. 2000;284(20):2582-2583. doi:10.1001/jama.284.20.2582-JMN1122-2-1

Chicago—Tissue engineering, only a theoretical possibility less than a decade ago, is moving closer to becoming a real discipline.

Researchers who presented their findings at the American College of Surgeons Clinical Congress here last month said they are making advances in engineering tissue for replacing heart valves and blood vessels and for treating ovarian cancer.

"This is perhaps the most rapidly developing, and potentially the most important, topic related to organ replacement and organ repair," said Dana K. Andersen, MD, professor and vice chair of the Department of Surgery at Yale University School of Medicine. "We're trying to focus attention on the science of directed growth and development of tissues and organs—which can be implanted into the patient—using the strategy of in vitro development."

First Page Preview View Large
First page PDF preview
First page PDF preview